Cholesterol buildup in lung immune cells triggers fibrosis in mice
Pulmonary fibrosis is a serious condition in which scar tissue builds up in the lungs. Researchers have found in mice that a lipid processing problem in immune cells can set off this process, before any visible damage occurs.
Macrophages are immune cells that play a key role in maintaining the lungs. Normally, they help repair injury. But when their fat metabolism goes wrong, they can drive fibrosis instead. Researchers studied mice lacking a protein called ABCG1, which normally controls the transport of cholesterol and other fats within cells. Without ABCG1, fats accumulated in lung macrophages.
Lipids activate connective tissue cells
According to the researchers, this fat accumulation occurred before any collagen was deposited or lung tissue was remodeled. Using detailed lipid profiling (lipidomics), they identified specific fat molecules that drive fibrosis. These molecules directly activated fibroblasts (connective tissue cells) and switched on fiber-producing genes, as shown in cell culture experiments.
The researchers then tested two approaches in mice: restoring cholesterol transport in macrophages, or blocking lipid uptake by fibroblasts. Both approaches prevented lung fibrosis in the animals. The research was published in the American Journal of Respiratory Cell and Molecular Biology.
Possible relevance for human lung fibrosis
Idiopathic pulmonary fibrosis (IPF) currently has no curative treatment. This study points to a specific mechanism: a fat-driven interaction between immune cells and the cells that produce scar tissue, which pushes the lung toward scarring. The researchers suggest that targeting fat metabolism in immune cells or blocking fat uptake by scar-forming cells could be treatment strategies. These are early findings from animal research. Whether this applies to humans was not investigated in this work.
Want to research this yourself?
Search for example:
- macrophage lipid metabolism pulmonary fibrosis | ABCG1 cholesterol transport lung tissue | fibroblast activation lipid signaling